Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China

Peer Review reports

Original Submission
25 Feb 2022	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
2 Apr 2022	Reviewed	Reviewer Report - Péter Kóthy
29 Jun 2022	Reviewed	Reviewer Report
13 Jul 2022	Author responded	Author comments - Xinghuai Sun
Resubmission - Version 3
13 Jul 2022	Submitted	Manuscript version 3
18 Jul 2022	Author responded	Author comments - Xinghuai Sun
Resubmission - Version 4
18 Jul 2022	Submitted	Manuscript version 4
Publishing
22 Jul 2022	Editorially accepted
5 Aug 2022	Article published	10.1186/s12886-022-02553-1

Back to article page